DTI-ALPS指数作为1年内认知能力下降的预测指标
Joo Jungwon1, Ji Hyung Lee1, Chi-Hoon Choi2
1Department of Psychiatry, Chungbuk National University Hospital, 1 Sunhwan-ro, Cheongju, 28644, Republic of Korea.
Neuroradiology
|December 16, 2024
概括
扩散张力成像分析沿周周血管空间 (DTI-ALPS) 指数,衡量大脑废物清除,与更好的认知功能和阿尔茨海默病 (AD) 患者的慢性衰退有关.
科学领域:
- 神经科学是一个神经科学.
- 放射学 放射学是一门学科.
- 老年学是指老年学的学科.
背景情况:
- 阿尔茨海默病 (AD) 是一种进展性神经退行性疾病,影响认知和日常功能.
- 淋巴系统清除神经毒性废物,包括在AD病变发生过程中至关重要的β-粉样蛋白 (Aβ).
- DTI-ALPS指数量化了淋巴功能,为AD进展提供了潜在的生物标志物.
研究的目的:
- 研究DTI-ALPS指数测量的淋巴功能与可能患有AD的患者的认知衰退之间的关系.
- 评估DTI-ALPS指数作为阿尔茨海默病认知能力下降的潜在预测指标.
主要方法:
- 一项纵向研究涉及16名可能患有AD的患者 (年龄在60-79岁),评估CDR和MMSE.
- 用DTI-ALPS指数评估淋巴功能,测量粉样蛋白病理的血Aβ 42/40比率.
- 多重回归模型分析了DTI-ALPS与基线认知之间的关联,并对共变量进行调整. 用MMSE得分变化来评估1年内的认知衰退.
主要成果:
- 更高的DTI-ALPS指数与更好的基线MMSE得分 (p<0.001) 和较低的CDR严重程度 (p=0.006) 有显著的相关性.
- 在1年的随访期间,基线DTI-ALPS指数值升高预测认知能力下降较少 (p=0.018).
结论:
- DTI-ALPS指数是与阿尔茨海默病的认知表现相关的有希望的生物标志物.
- 这一指数可以作为阿尔茨海默病患者认知能力下降的预测工具.
- 建议对更大的队列进行进一步研究,并扩大随访时间以验证这些发现.
更多相关视频
12:18A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
Published on: January 11, 2020
7.5K
06:46Automated, Long-term Behavioral Assay for Cognitive Functions in Multiple Genetic Models of Alzheimer's Disease, Using IntelliCage
Published on: August 4, 2018
12.1K
相关概念视频
Cognitive Development During Adulthood
50
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
50
Dementia
94
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
94
Alzheimer's Disease: Overview
444
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
444
